<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Age at first stroke and cumulative incidence of stroke in SCD according to the type of SCD</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Age at first stroke and cumulative incidence of stroke in SCD according to the type of SCD</h1>
<div class="graphic"><div class="figure"><div class="ttl">Age at first stroke and cumulative incidence of stroke in SCD according to the type of SCD</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Age at first stroke (ischemic or hemorrhagic) and cumulative incidence of stroke in 2436 patients with sickle cell disease. The graph shows the percentage of individuals without a stroke. These data largely represent patients who did not receive primary prevention. The number of patients of each type is as follows:
<ul>
<li>Hb SS – 2346</li>
<li>Hb S-beta<sup>0</sup> thalassemia – 188</li>
<li>Hb S-beta<sup>+</sup> thalassemia – 184</li>
<li>Hb SC disease – 839</li>
</ul></div><div class="graphic_footnotes">SCD: Sickle cell disease.</div><div class="graphic_reference">Adapted from Ohene-Frempong, K, Weiner, SJ, Sleeper, LA, et al, Blood 1998; 91:288.</div><div id="graphicVersion">Graphic 61397 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
